ARCHER MATERIALS ORD
Archer Materials Unveils Clinically Accurate Biochip Prototype, Eyes MedTech Partnerships
Archer Materials (ASX: AXE) has achieved a significant milestone with its Biochip technology, unveiling an alpha prototype of a potassium sensor that meets clinical-grade accuracy standards.
Archer Materials Advances Carbon Qubit and Biochip Programs with Key Technical Milestones
Archer Materials advances carbon qubit 12CQ readout; silicon biochip hits potassium accuracy with IMEC; collabs with Emergence Quantum and CSIRO.
Archer’s Biochip: What Does Silicon Integration Mean?
For many investors, the word "silicon" calls to mind the computer revolution of the 80s and 90s, but for Archer Materials (ASX: AXE), it represents a potential lifeline for kidney disease patients and a pathway to scalable manufacturing for a medical device.
Archer Materials Achieves Read-Out Milestone on Roadmap to Qubit Demonstration
Archer Materials (ASX: AXE) has achieved a key milestone on the journey to qubit demonstration by showing it can electrically-control its quantum device to enable an accurate read-out of quantum information.
